Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
| Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
|---|---|---|---|---|---|---|---|
| BPS-82481 | 1 vial | - | - |
3 - 8 business days* |
2,992.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Anti-CD19/CD20 CAR-T Cells are produced by high-titer lentiviral transduction of human primary... more
Product information "Anti-CD19/CD20 CAR-T Cells"
Anti-CD19/CD20 CAR-T Cells are produced by high-titer lentiviral transduction of human primary CD4+ and CD8+ T cells using Anti-CD19/CD20 CAR Lentivirus. These ready-to-use CAR (chimeric antigen receptor)-T cells express an anti-CD19/CD20 CAR consisting of the ScFv portions of both anti-CD20 (Clone OMB-157) and anti-CD19 (clone FMC63) linked to a second generation CAR containing IgG4 hinge and CD28 transmembrane domains, 4-1BB and CD3zeta signaling domains (Figure 1).These CAR-T cells have been validated using flow cytometry (to determine CAR expression) and co-culture cytotoxicity assays. Figure 1. Construct diagram showing components of the Anti-CD19/CD20 CAR expressed in Anti-CD19/CD20 CAR-T Cells.
| Keywords: | CD19, B-lymphocyte antigen CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte surface antigen B4, |
| Supplier: | BPS Bioscience |
| Supplier-Nr: | 82481 |
Properties
| Application: | CAR-T cell development positive control, modulator screening, co-culture cytotoxicity assay desig |
| Species reactivity: | human |
Database Information
| KEGG ID : | K06465 | Matching products |
| UniProt ID : | P15391 | Matching products |
| Gene ID : | GeneID 930 | Matching products |
Handling & Safety
| Storage: | Liquid nitrogen |
| Shipping: | -80°C (International: °C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed